Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Graham MD

David Y. Graham MD

Professor of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine and the Michael E. DeBakey VA Medical Center, Houston, Texas

David Y. Graham, M.D., is a Professor in the Departments of Medicine and Molecular Virology and Microbiology at Baylor College of Medicine and the Michael E. DeBakey VA Medical Center in Houston.  He received his undergraduate degree from the University of Notre Dame in South Bend, Indiana, his M.D. degree with honor from Baylor University College of Medicine in 1966.  He board certified in Medicine and Gastroenterology.  Dr. Graham is a Past President of the American College of Gastroenterology.  He is currently the Editor of the journal "Helicobacter" and the author of more than 1100 scientific papers, several books, and more than 100 chapters in medical textbooks. Dr. Graham has been listed as among the Top 50 Most Influential Gastroenterology Professionals of the 20th Century by Vgastroenterology.com, as one of ISI's Highly Cited Researcher in Clinical Medicine and as one of the Best Doctors in America.

Disclosures

Dr. Graham is supported in part by the Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service grant DK56338 which funds the Texas Medical Center Digestive Diseases Center.

Dr. Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel H. pylori therapies and has received research support for culture of Helicobacter pylori. He is also a consultant for DiaSorin regarding H. pylori diagnostics and with Otsuka Japan regarding novel breath tests. He has ongoing collaborative research projects with American Molecular Laboratories regarding molecular diagnostics for H. pylori. 

Recent Contributions to PracticeUpdate:

  1. Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment
  2. Clarithromycin-Based Treatment for H. pylori Infections
  3. Association Between Host Genetic Determinants and Helicobacter pylori Eradication Treatment Failure
  4. Severity of Gastric Intestinal Metaplasia Predicts Risk of Gastric Cancer

Most Read This Week

Recently Updated